Roger Zhang
Senior Associate at Samsara BioCapital
San Francisco, California
Overview
Work Experience
Senior Associate
2023 - Current
Associate
2021 - 2023
Senior Analyst
2020 - 2021
Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.
Board Member
2023
Spyglass Pharma provides medicine for ophthalmic diseases.
Raised $109,782,347.00 from RA Capital Management, Vertex Ventures HC, New Enterprise Associates, Samsara BioCapital and Vensana Capital.
Board Member
2021
Respiras high efficiency AOS Dry Powder Inhaler (DPI) technologies deliver dry powder drug products to the lung more effectively.
Raised $5,100,000.00 from Keiretsu Forum Northwest.
Board Observer
2021 - 2023
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Raised $278,000,000.00 from Venrock Healthcare Capital Partners, OrbiMed, Samsara BioCapital, TCG Crossover and RA Capital Management.
Board Observer
2021 - 2023
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
Raised $310,000,000.00 from Woodline Partners, Ally Bridge Group, Saturn V Capital, Novo Holdings, Perceptive Advisors, T. Rowe Price, Wellington Management, Third Rock Ventures, Opaleye Management and Samsara BioCapital.
PhD Student
2014 - 2020
Virology Intern
2012 - 2013
Roche Molecular Systems, Inc., a molecular diagnostics company, develops and commercializes diagnostic and blood screening tests based on